Laurion Capital Management LP Intra Cellular Therapies, Inc. Transaction History

Laurion Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$64.76 - $79.84 $600,325 - $740,116	9,270 New	9,270 $634,000
Q4 2020 Feb 12, 2021	SELL	$23.34 - $32.22 $4.08 Million - $5.64 Million	-175,000 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$17.61 - $31.86 $3.08 Million - $5.58 Million	175,000 New	175,000 $4.49 Million
Q2 2020 Aug 14, 2020	SELL	$14.35 - $26.64 $2.15 Million - $4 Million	-150,000 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$12.31 - $33.12 $1.85 Million - $4.97 Million	150,000 New	150,000 $2.31 Million
Q1 2018 May 14, 2018	SELL	$15.16 - $25.49 $3.43 Million - $5.76 Million	-226,160 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$14.27 - $16.79 $4.62 Million - $5.44 Million	-323,840 Reduced 58.88%	226,160 $3.28 Million
Q3 2017 Nov 13, 2017	BUY	$10.77 - $22.1 $5.92 Million - $12.2 Million	550,000	550,000 $8.68 Million

379

84.7M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.87B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.